Tag: CBT > Cannabis DEA: Page 6

International

Jamaica Company Ships 1st Legal Exports of THC to United States For DEA Testing

Pure Jamaican elevates Jamaica as a global provider of legal cannabis with pharmaceutical THC product exports to the U.S. and Brazil.

February 22, 2024

International

Behind DEA’s 1975 Admission That Rescheduling Cannabis Does Not Violate International Treaty

The DEA’s refusal to reschedule cannabis nearly 50 years ago derived from HHS predecessor’s failure to recognize its medical value, not a 1961 treaty.

February 22, 2024

Legislation and Regulation

DEA, Attorney General Miss Deadline to Respond to 12 US Senators on Cannabis Rescheduling

The Drug Enforcement Administration continues to keep its process behind closed doors despite a congressional letter demanding transparency.

February 14, 2024

Federal Cannabis Legalization

VP Kamala Harris Touts Changing ‘Federal Marijuana Policy’ in Campaign Video

Many industry stakeholders and advocates pushed back, saying the White House hasn’t changed anything since Biden took office.

February 12, 2024

Cannabis Rescheduling

Congressman Presses DEA For Answers on Ongoing Cannabis Scheduling Review

U.S. Rep. Earl Blumenauer wrote to DEA Administrator Anne Milgram Feb. 8 for further details on the review process, including when the agency might publish its draft rule on the scheduling of cannabis.

February 8, 2024

Impacts of Cannabis Legalization

Cannabis Reform Momentum Unprecedented in Recent Years

In the past three years, the federal government has taken steps to provide more access to research, rescheduling may be on the horizon and nearly half of U.S. states have legalized adult-use cannabis.

February 8, 2024

Cannabis Rescheduling

US Congressman Attempts to Sway DEA From Rescheduling Cannabis

Rep. Andy Harris claims the FDA’s eight-factor analysis on cannabis was “flawed,” leading to a “misguided” recommendation to reschedule.

February 2, 2024

Legislation and Regulation

12 US Senators Say Cannabis Should Be Descheduled, Demand Transparency From DEA

The dozen Democrats requested responses to six questions regarding the DEA’s rescheduling process.

January 30, 2024

Cannabis Retail Price

Rescheduling, Legalization Prospects Top CBT's Most-Read Articles in January

Here are Cannabis Business Times’ top 10 stories this month.

January 25, 2024

Cannabis Rescheduling

Colorado Attorney General Leads Multistate Effort to Support Cannabis Rescheduling

Attorney General Phil Weiser spearheaded a letter signed by 11 other state attorneys general to encourage the Drug Enforcement Administration to reclassify cannabis as a Schedule III drug under the Controlled Substances Act.

January 16, 2024

Cannabis Rescheduling

US Congressman Urges DEA to Expedite Rescheduling Cannabis

Rep. Steve Cohen of Tennessee wrote a letter to Administrator Anne Milgram pushing to initiate the rulemaking process “quickly.”

January 5, 2024

Cannabis Rescheduling

Industry Attorney Weighs in on Possible Cannabis Rescheduling Timeline: ‘It Normally Takes Years and Years for This to Get Done’

Despite the U.S. Drug Enforcement Administration’s recent response to a letter from Rep. Earl Blumenauer urging the agency to deschedule cannabis, Porter Wright Morris & Arthur’s Shane Pennington says it could be after the 2024 election before federal officials come to a decision on cannabis’s Schedule I status.

January 4, 2024